Milton Werner
Founder bij INHIBIKASE THERAPEUTICS, INC.
Vermogen: 2 M $ op 31-03-2024
Profiel
Milton H.
Werner is the founder of Inhibikase Therapeutics, Inc. which was founded in 2008.
He holds the title of President, Chief Executive Officer & Director at Inhibikase Therapeutics, Inc. starting in 2012.
Dr. Werner is currently a Member at Winship Cancer Institute.
In the past, he worked as Vice President-Research at Celtaxsys, Inc. in 2007 and as Head-Laboratory of Molecular Biophysics at The Rockefeller University from 1996 to 2007.
Dr. Werner completed his undergraduate degree at the University of Southern California in 1985 and obtained his doctorate degree from the University of California, Berkeley in 1991.
Bekende belangen in openbare bedrijven
Onderneming | Datum | Aantal aandelen | Totale waarde | Waarderingsdatum |
---|---|---|---|---|
01-04-2024 | 889 230 ( 14.37% ) | 2 M $ | 31-03-2024 |
Actieve functies van Milton Werner
Bedrijven | Functie | Begin |
---|---|---|
INHIBIKASE THERAPEUTICS, INC. | Founder | 01-09-2008 |
Winship Cancer Institute | Corporate Officer/Principal | - |
Eerdere bekende functies van Milton Werner
Bedrijven | Functie | Einde |
---|---|---|
Celtaxsys, Inc.
Celtaxsys, Inc. Pharmaceuticals: MajorHealth Technology Celtaxsys, Inc. operates as a clinical-stage drug discovery and development company that focuses on novel therapeutics to treat patients suffering from inflammatory diseases. It offers CTX-4430, a small-molecule drug that targets the enzyme Leukotriene A4 hydrolase in immune cells for the treatment of cystic fibrosis and moderately severe acne diseases. The company was founded by William P. Reddick in 2005 and is headquartered in Atlanta, GA. | Chief Tech/Sci/R&D Officer | 01-08-2007 |
The Rockefeller University | Corporate Officer/Principal | 01-06-2007 |
Opleiding van Milton Werner
University of Southern California | Undergraduate Degree |
University of California, Berkeley | Doctorate Degree |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
Beursgenoteerde bedrijven | 1 |
---|---|
INHIBIKASE THERAPEUTICS, INC. | Health Technology |
Bedrijven in privébezit | 2 |
---|---|
Celtaxsys, Inc.
Celtaxsys, Inc. Pharmaceuticals: MajorHealth Technology Celtaxsys, Inc. operates as a clinical-stage drug discovery and development company that focuses on novel therapeutics to treat patients suffering from inflammatory diseases. It offers CTX-4430, a small-molecule drug that targets the enzyme Leukotriene A4 hydrolase in immune cells for the treatment of cystic fibrosis and moderately severe acne diseases. The company was founded by William P. Reddick in 2005 and is headquartered in Atlanta, GA. | Health Technology |
Winship Cancer Institute |